Brief Summary of the Main Points

A Resident of the Technopolis Moscow SEZ Receives the National "Made in Russia" Label
A Resident of the Technopolis Moscow SEZ Receives the National "Made in Russia" Label

GemaTech, a company specializing in the production of medical devices, has been awarded the "Made in Russia" certificate by the Russian Export Center.

26.06.2025
Ministry Registers Domestic Drug for Anxiety Disorders
Ministry Registers Domestic Drug for Anxiety Disorders

The Ministry has registered the Russian-made drug Marituperdin for treating anxiety disorders. Its uniqueness lies in its multi-target mechanism, providing both anxiolytic and antidepressant effects, according to ...

25.03.2025
Ministry of Health Removes Evalar’s Levocarnitine Substance from GRLS
Ministry of Health Removes Evalar’s Levocarnitine Substance from GRLS

The Ministry of Health has excluded the registration certificate for the pharmaceutical substance levocarnitine (trade name: Levocarnitine) produced by Russian company Evalar from the GRLS. This drug is used globally for serious kidney diseases requiring dialysis. ...

21.03.2025
Ministry of Health Expands List of Side Effects for Cefpodoxime-Containing Drugs
Ministry of Health Expands List of Side Effects for Cefpodoxime-Containing Drugs

The Ministry’s Department for Drug and Medical Device Regulation issued a notice to manufacturers of cefpodoxime-based antibiotics (included in the Essential Drugs List). The notice requires updates to the Summary of Product Characteristics and ...

21.03.2025
GemaTech – Partner of the Colorectal Surgery Master Class
GemaTech – Partner of the Colorectal Surgery Master Class

Another successful master class of the Russian Society of Colorectal Surgeons was held in St. Petersburg – an event that brings together leading coloproctology experts from Russia and abroad. “GemaTech,” an active ...

20.03.2025
Ministry of Health Updates Draft Procedure for Clinical Guideline Application
Ministry of Health Updates Draft Procedure for Clinical Guideline Application

The Russian Ministry of Health has submitted a revised draft of the order “On Approval of the Procedure for the Use of Clinical Guidelines (CG)” for approval by professional associations. Published on ...

20.03.2025
Ministry of Health Cancels Registrations for 6 Medications
Ministry of Health Cancels Registrations for 6 Medications

The Russian Ministry of Health has canceled registration certificates for six drugs, based on requests from the authorized legal entities. Three of the drugs are produced by JSC Khimfarm: Akrimex (ethylmethylhydroxypyridine succinate), ...

20.03.2025
Ministry of Health Registers Original Biocad Drug for Systemic Scleroderma
Ministry of Health Registers Original Biocad Drug for Systemic Scleroderma

The Ministry of Health of the Russian Federation has approved the use of divozilumab, developed by Biocad, for a new indication – systemic scleroderma.

19.03.2025
Ministry of Health Approves Clinical Trial of Drug for Diabetic Foot Syndrome
Ministry of Health Approves Clinical Trial of Drug for Diabetic Foot Syndrome

The Ministry of Health has authorized Nextgen (Artgen Biotech) to conduct a Phase III clinical trial of the gene therapy drug Neovasculgen for the treatment of diabetic foot syndrome. The study will involve 188 patients across ...

12.03.2025
Ministry of Health Cancels Registration of 43 Medicinal Products
Ministry of Health Cancels Registration of 43 Medicinal Products

The Ministry of Health has canceled the state registration of 43 drugs and one pharmaceutical substance. The majority of these (31 products) are manufactured by Sandoz. Additionally, the use of two drugs was suspended, according to ...

12.03.2025